Press releases

13
Apr 2020
20:30 E.S.T.

Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer

Read more
10
Mar 2020
20:30 E.S.T.

US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis

Read more
4
Mar 2020
21:30 E.S.T.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results

Read more
4
Mar 2020
21:05 E.S.T.

Cellectis and Servier Execute the Amendment Confirming the Expansion of their Collaboration on UCART19 Products

Read more
25
Feb 2020
21:30 E.S.T.

Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST

Read more
18
Feb 2020
21:30 E.S.T.

Cellectis and Servier Expand Collaboration on UCART19 Products

Read more
15
Jan 2020
21:30 E.S.T.

First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia

Read more
12
Jan 2020
21:00 E.S.T.

Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement

Read more
6
Jan 2020
21:30 E.S.T.

An Expert Review on Allogeneic CAR-T for Cancer Published in Nature Reviews Drug Discovery

Read more
2
Dec 2019
21:30 E.S.T.

1st Patient Dosed with Cellectis’ Allogeneic UCART22 in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US